Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Alternext  >  Neovacs    ALNEV   FR0004032746

NEOVACS (ALNEV)

Delayed Quote. Delayed  - 07/01 09:28:49 am
0.73 EUR   -1.35%
06/23 NEOVACS : EUR 8 million capital increase successfully completed
05/30 NEOVACS : to Present at Bio International Convention 2016
05/30 NEOVACS : to Present at Bio International Convention 2016
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Alternext
06/27/2016 06/28/2016 06/29/2016 06/30/2016 07/01/2016 Date
0.72(c) 0.75(c) 0.75(c) 0.74(c) 0.73 Last
352 578 686 144 532 380 590 195 41 543 Volume
0.00% +4.17% 0.00% -1.33% -1.35% Change
More quotes
Financials (€)
Sales 2016 0,10 M
EBIT 2016 -10,3 M
Net income 2016 -7,90 M
Debt 2016 4,00 M
Yield 2016 -
Sales 2017 0,10 M
EBIT 2017 4,98 M
Net income 2017 -9,90 M
Finance 2017 37,0 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017 0,78
EV / Sales2016 355x
EV / Sales2017 -54,8x
Capitalization 31,5 M
More Financials
Company
Neovacs SA is a biotechnology company which engages in the development of active immunotherapies for treating auto-immune, inflammatory, and cancerous diseases.It focuses on the development of Tumor Necrosis Factor-Kinoid for treating Crohn's disease and rheumatoid polyarthritis, and... 
More about the company
Latest news on NEOVACS
06/23 NEOVACS : EUR 8 million capital increase successfully completed
05/30 NEOVACS : to Present at Bio International Convention 2016
05/30 NEOVACS : to Present at Bio International Convention 2016
05/30 DGAP-NEWS : Neovacs to Present at Bio International Convention 2016
05/17 DGAP-NEWS : Neovacs to attend ChinaBio(R) Event May 18 & 19, 2016
05/17 NEOVACS : to attend ChinaBio® Event May 18 & 19, 2016
05/12 NEOVACS : and Stellar Biotechnologies sign joint venture agreement to create Neo..
05/12 DGAP-NEWS : Neovacs and Stellar Biotechnologies sign a joint venture agreement t..
04/29 NEOVACS : obtains FDA approval to extend its Phase IIb clinical trial in Lupus t..
04/28 NEOVACS : obtains FDA approval to extend its Phase IIb clinical trial in Lupus t..
More news
Sector news : Biotechnology & Medical Research - NEC
06/28DJGILEAD SCIENCES : Gets FDA Approval for Combo Hepatitis C Drug
06/28DJGILEAD SCIENCES : Gets FDA Approval for Combo Hepatitis C Drug
06/28DJGILEAD SCIENCES : Gets FDA Approval for Combo Hepatitis C Drug
06/24DJMedpace Files for IPO
06/24DJMEDIVATION : Glass Lewis Backs Medivation Board in Sanofi Dispute
More sector news : Biotechnology & Medical Research - NEC
Advertisement
Chart NEOVACS
Duration : Period :
Neovacs Technical Analysis Chart | ALNEV | FR0004032746 | 4-Traders
Full-screen chart
Technical analysis trends NEOVACS
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials